This company has been acquired
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
DICE Therapeutics Gestion
Gestion contrôle des critères 2/4
We currently do not have sufficient information about the CEO.
Informations clés
J. Judice
Directeur général
US$5.8m
Rémunération totale
Pourcentage du salaire du PDG | 9.4% |
Durée du mandat du directeur général | 10yrs |
Propriété du PDG | 1.7% |
Durée moyenne d'occupation des postes de direction | 2.6yrs |
Durée moyenne du mandat des membres du conseil d'administration | 2.7yrs |
Mises à jour récentes de la gestion
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2023 | n/a | n/a | -US$104m |
Mar 31 2023 | n/a | n/a | -US$91m |
Dec 31 2022 | US$6m | US$540k | -US$84m |
Sep 30 2022 | n/a | n/a | -US$77m |
Jun 30 2022 | n/a | n/a | -US$74m |
Mar 31 2022 | n/a | n/a | -US$59m |
Dec 31 2021 | US$6m | US$465k | -US$49m |
Sep 30 2021 | n/a | n/a | -US$40m |
Jun 30 2021 | n/a | n/a | -US$29m |
Mar 31 2021 | n/a | n/a | -US$27m |
Dec 31 2020 | US$637k | US$437k | -US$24m |
Rémunération vs marché: J.'s total compensation ($USD5.77M) is about average for companies of similar size in the US market ($USD5.11M).
Rémunération et revenus: J.'s compensation has increased whilst the company is unprofitable.
PDG
J. Judice (59 yo)
10yrs
Titularisation
US$5,773,577
Compensation
Dr. J. Kevin Judice, Ph D., founded DiCE Molecules SV, Inc. (formerly known as DiCE Molecules Corp). and serves as its Chief Executive Officer, President and Secretary. Dr. Judice has extensive experience...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Founder | 10yrs | US$5.77m | 1.67% $ 38.0m | |
Chief Business & Financial Officer | 5.7yrs | US$2.67m | 0.41% $ 9.4m | |
Chief Medical Officer | 3yrs | US$2.72m | 0.32% $ 7.2m | |
Chief Scientific Officer | 2.2yrs | US$714.79k | 0.31% $ 7.0m | |
General Counsel | 1.4yrs | pas de données | pas de données | |
Senior Vice President of CMC | 2.2yrs | pas de données | pas de données | |
Senior Vice President of Medicinal Chemistry | no data | pas de données | pas de données |
2.6yrs
Durée moyenne de l'emploi
54yo
Âge moyen
Gestion expérimentée: DICE's management team is considered experienced (2.6 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Founder | no data | US$5.77m | 1.67% $ 38.0m | |
Independent Director | 2.8yrs | US$264.90k | 0.10% $ 2.4m | |
Independent Chairman of the Board | 7.7yrs | US$371.88k | 0.018% $ 400.6k | |
Independent Director | 2.8yrs | US$264.90k | 0.086% $ 1.9m | |
Independent Director | 1.4yrs | US$552.51k | 0% $ 0 | |
Independent Director | 2.7yrs | US$231.45k | pas de données | |
Independent Director | 1.4yrs | US$552.51k | 0% $ 0 |
2.7yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Conseil d'administration expérimenté: DICE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.